Washington — President Donald Trump unveiled TrumpRx.gov on Thursday, a website designed to connect consumers with discounted prescription medicines. The White House announced a 7 p.m. ET launch and said the site will link users to manufacturers’ direct-purchase platforms rather than dispense drugs. Trump announced the initiative with CMS Administrator Dr. Mehmet Oz and National Design Studio Director Joe Gebbia. The administration said over a dozen drugmakers signed most-favored-nation agreements to offer lower cash prices, with GoodRx named a key integration partner. Officials said some GLP-1 prices could fall to $149–$350 per month. Based on 6 articles reviewed and supporting research.
Prepared by Lauren Mitchell and reviewed by editorial team.
Consumers paying cash for prescription drugs may benefit from lower listed cash prices via TrumpRx, participating drugmakers may gain broader U.S. market access under MFN arrangements, and partners like GoodRx could see increased transaction volume.
Non-participating pharmacies and intermediaries could lose cash sales; patients without direct manufacturer channels or who rely on pharmacy dispensing may still face access or practical barriers despite listed discounts.
No left-leaning sources found for this story.
Washington launches TrumpRx website to lower drug costs
KOKH News Directory 3 heidoh.com Weekly Voice Free Malaysia TodayTrump to officially launch TrumpRX, offering affordable prescription drugs to Americans
KRCR
Comments